NCT05029440

Pulsed Electromagnetic Field Versus Pulsed High Intensity Laser in the of Osteoprosis

Completed NA Last updated 31 August 2021

What this trial tests

NA trial testing Pulsed Electromagnetic Field in Osteopenia or Osteoporosis in 90 participants. Completed in 25 May 2021.

Timeline

1 February 2021

Primary endpoint
15 May 2021

25 May 2021

Quick facts

Lead sponsor	Umm Al-Qura University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	double
Primary purpose	treatment
Enrollment	90
Start date	1 February 2021
Primary completion	15 May 2021
Estimated completion	25 May 2021
Sites	1 location across Saudi Arabia

Drugs / interventions tested

• Pulsed Electromagnetic Field
• Exercise Program
• Pulsed High Laser Therapy

Conditions studied

• Osteopenia or Osteoporosis — all drugs for Osteopenia or Osteoporosis →

Sponsor

Umm Al-Qura University

Who can join

Adults 30 to 60, any sex, with Osteopenia or Osteoporosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Osteoporosis is the most prevalent metabolic bone disease. Although osteoporosis is widely considered to be much more prevalent in women approximately 39% of new osteoporotic fractures estimated to have occurred Worldwide in 2000 were in men. A number of studies investigate the effect of physical therapy modalities in treatment of osteoporosis. The use of pulsed electromagnetic field (PEMF) represents an attractive alternative for Osteoporosis. Previous studies suggested that pulsed electromagnetic field could be beneficial for increase bone mineral density in osteoporotic patients, but there is a lack of Knowledge about the comparison with pulsed high laser therapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Effect of pulsed electromagnetic field versus pulsed high intensity laser in the treatment of men with osteopenia or osteoporosis: a randomized controlled trial
   Ebid A, El-Shamy S, Thabet A, El-boshy M, et al · · 2022 · DOI 10.12688/f1000research.75334.1